Maverix Metals Inc. (NYSE:MMX) Given Consensus Recommendation of “Buy” by Analysts

Share on StockTwits

Shares of Maverix Metals Inc. (NYSE:MMX) have been given a consensus rating of “Buy” by the six analysts that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $7.17.

MMX has been the subject of a number of analyst reports. CIBC initiated coverage on Maverix Metals in a research report on Wednesday, December 18th. They set an “outperformer” rating and a $7.75 price objective for the company. Zacks Investment Research raised Maverix Metals from a “sell” rating to a “hold” rating in a research report on Saturday, February 15th. Finally, Cantor Fitzgerald raised Maverix Metals from a “neutral” rating to an “overweight” rating in a research report on Tuesday, December 3rd.

Hedge funds have recently bought and sold shares of the stock. Sprott Inc. increased its position in Maverix Metals by 17.1% during the 4th quarter. Sprott Inc. now owns 244,101 shares of the company’s stock valued at $1,393,000 after buying an additional 35,718 shares in the last quarter. Integrated Advisors Network LLC bought a new position in Maverix Metals during the 4th quarter valued at approximately $166,000. Penbrook Management LLC bought a new position in Maverix Metals during the 4th quarter valued at approximately $51,000. Renaissance Technologies LLC bought a new position in Maverix Metals during the 4th quarter valued at approximately $1,307,000. Finally, Amundi Pioneer Asset Management Inc. bought a new position in Maverix Metals during the 4th quarter valued at approximately $609,000. 5.74% of the stock is owned by institutional investors.

Shares of NYSE:MMX opened at $3.59 on Friday. Maverix Metals has a 52-week low of $2.51 and a 52-week high of $5.72. The firm has a market capitalization of $423.94 million and a P/E ratio of -59.82. The stock has a 50 day moving average price of $4.14 and a 200-day moving average price of $4.44. The company has a debt-to-equity ratio of 0.29, a quick ratio of 6.10 and a current ratio of 5.50.

Maverix Metals (NYSE:MMX) last announced its earnings results on Thursday, March 5th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.01. Maverix Metals had a positive return on equity of 3.30% and a negative net margin of 22.20%. The firm had revenue of $10.31 million during the quarter, compared to analyst estimates of $9.98 million. On average, equities analysts forecast that Maverix Metals will post 0.1 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Tuesday, March 31st will be given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 1.11%. The ex-dividend date is Monday, March 30th. Maverix Metals’s dividend payout ratio (DPR) is presently 66.67%.

About Maverix Metals

Maverix Metals Inc, a precious metals royalty and streaming company, engages in the exploration and development of mineral properties. The company explores for gold, silver, and other precious metals. It holds a portfolio of 46 development and exploration stage royalties in the United States, Canada, Australia, and internationally.

Recommended Story: S&P/TSX Index

Receive News & Ratings for Maverix Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maverix Metals and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Nuveen Asset Management LLC Has $48.56 Million Stake in Discovery Communications Inc.
Nuveen Asset Management LLC Has $48.56 Million Stake in Discovery Communications Inc.
Norges Bank Makes New Investment in Charles River Laboratories Intl. Inc
Norges Bank Makes New Investment in Charles River Laboratories Intl. Inc
Macquarie Group Ltd. Has $9.21 Million Stock Position in HCA Healthcare Inc
Macquarie Group Ltd. Has $9.21 Million Stock Position in HCA Healthcare Inc
Cardiovascular Systems  Given New $54.00 Price Target at Lake Street Capital
Cardiovascular Systems Given New $54.00 Price Target at Lake Street Capital
Janus Henderson Group PLC Buys New Stake in Associated Banc Corp
Janus Henderson Group PLC Buys New Stake in Associated Banc Corp
Brunswick Co.  Shares Purchased by Nuveen Asset Management LLC
Brunswick Co. Shares Purchased by Nuveen Asset Management LLC


© 2006-2020 Ticker Report